PXMD vs. EVLO, AMPE, CMRA, CALA, EFTR, HSTO, ATNFW, LBPSW, AIMDW, and ALVOW
Should you be buying PaxMedica stock or one of its competitors? The main competitors of PaxMedica include Evelo Biosciences (EVLO), Ampio Pharmaceuticals (AMPE), Comera Life Sciences (CMRA), Calithera Biosciences (CALA), eFFECTOR Therapeutics (EFTR), Histogen (HSTO), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Ainos (AIMDW), and Alvotech (ALVOW). These companies are all part of the "pharmaceutical products" industry.
PaxMedica vs. Its Competitors
PaxMedica (NASDAQ:PXMD) and Evelo Biosciences (NASDAQ:EVLO) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, valuation, earnings, risk and dividends.
Evelo Biosciences' return on equity of 0.00% beat PaxMedica's return on equity.
In the previous week, Evelo Biosciences' average media sentiment score of 0.32 beat PaxMedica's score of 0.00 indicating that Evelo Biosciences is being referred to more favorably in the news media.
4.9% of PaxMedica shares are held by institutional investors. Comparatively, 0.3% of Evelo Biosciences shares are held by institutional investors. 1.0% of PaxMedica shares are held by insiders. Comparatively, 1.0% of Evelo Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
PaxMedica has a beta of -0.99, indicating that its stock price is 199% less volatile than the S&P 500. Comparatively, Evelo Biosciences has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500.
Summary
Evelo Biosciences beats PaxMedica on 5 of the 7 factors compared between the two stocks.
Get PaxMedica News Delivered to You Automatically
Sign up to receive the latest news and ratings for PXMD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding PXMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
PaxMedica Competitors List
Related Companies and Tools
This page (NASDAQ:PXMD) was last updated on 10/24/2025 by MarketBeat.com Staff